½ÃÀ庸°í¼­
»óǰÄÚµå
1339240

¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå Á¡À¯À², ±Ô¸ð, µ¿Çâ, »ê¾÷ ºÐ¼® ¸®Æ÷Æ® : ±â¼úº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2023-2032³â)

Microbiome Sequencing Services Market Share, Size, Trends, Industry Analysis Report, By Technology (Sequencing by Synthesis, Sequencing by Ligation, Sanger Sequencing); By Application; By End-user; By Region, And Segment Forecasts, 2023 - 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Polaris Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 112 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Polaris Market ResearchÀÇ ÃֽŠÁ¶»ç¿¡ µû¸£¸é ¼¼°èÀÇ ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå ±Ô¸ð´Â 2032³â±îÁö 10¾ï 3,239¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù. ÀÌ Á¶»ç ¸®Æ÷Æ®´Â ÇöÀçÀÇ ½ÃÀå ¿ªÇÐÀ» »ó¼¼ ÀλçÀÌÆ®Çϰí, ÇâÈÄ ½ÃÀå ¼ºÀå¿¡ °üÇÑ ºÐ¼®À» Á¦°øÇϰí ÀÖ½À´Ï´Ù.

¹Ì»ý¹° ±ºÁýÀÌ Àΰ£ÀÇ °Ç°­¿¡ ¹ÌÄ¡´Â ¿µÇâÀÌ Å©±â ¶§¹®¿¡ ÃÖ±Ù ¼ö³â°£ ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¿¬±¸°¡ Å©°Ô ¹ßÀüÇϰí ÀÖ½À´Ï´Ù. ½ÃÄö½Ì ±â¼úÀÇ ¹ßÀü°ú ºñ¿ëÀÇ ´ëÆøÀûÀÎ Àý°¨À¸·Î ÀÎÇØ ÀÎü³» ¹× ÀÎü¿¡ Á¸ÀçÇÏ´Â ¹Ì»ý¹°ÀÇ ´Ù¾ç¼º¿¡ ´ëÇÑ ¿¬±¸¸¦ ½±°Ô ¼öÇàÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¾Ï, ÀÚ°¡¸é¿ªÁúȯ, °¨¿°¼º Áúȯ µî ´Ù¾çÇÑ Áúº´ÀÇ »õ·Î¿î Ä¡·á¹ý°ú ¿¹¹æ¹ýÀ» °³¹ßÇÒ ¼ö ÀÖ´Â °¡´É¼ºÀ¸·Î ÀÎÇØ ÀÎü ¸¶ÀÌÅ©·Î¹ÙÀÌ¿ÈÀÌ ÀÎü »ý¸®Çп¡ ¹ÌÄ¡´Â ¿µÇâ¿¡ ´ëÇÑ ¿¬±¸°¡ Ȱ¹ßÈ÷ ÁøÇàµÇ°í ÀÖ½À´Ï´Ù. °úÇÐÀÚ ¹× ¿¬±¸ÀÚµéÀÌ ¸¶ÀÌÅ©·Î¹ÙÀ̿Ȱú ÀÎü °Ç°­ÀÇ °ü°è¸¦ °è¼Ó ޱ¸Çϰí ÀÖÀ¸¹Ç·Î ÀÌ ºÐ¾ßÀÇ ¿¬±¸ È®´ë´Â ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇÒ °¡´É¼ºÀÌ ³ô½À´Ï´Ù.

COVID-19 ÆÒµ¥¹ÍÀº ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. ƯÈ÷ °¨¿°º´ ¹× ¾Ï ¿¬±¸ ºÐ¾ß¿¡¼­ ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ÅøÀÇ Ã¤ÅÃÀ» Áõ°¡½ÃŰ´Â °è±â°¡ µÇ¾ú½À´Ï´Ù. ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½ÌÀÇ ¿ëµµ Áß ÇϳªÀÎ RNA ½ÃÄö½ÌÀº ¹ÙÀÌ·¯½ºÀÇ Á¸Àç¿Í COVID-19¿¡ ´ëÇÑ ¼÷ÁÖÀÇ ¹ÝÀÀÀ» ÆÇ´ÜÇÏ´Â µ¥ Ȱ¿ëµÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ ÆÒµ¥¹Í »óȲ¿¡¼­ ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ¹× Åø¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ÇâÈÄ ¼ö³â°£ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

COVID-19 ¿¬±¸¿¡ ´ëÇÑ Á¤ºÎÀÇ ÀÚ±Ý Áö¿ø°ú ¾÷°è Âü¿©ÀÚµé°úÀÇ Á¦ÈÞµµ ÆÒµ¥¹Í ±â°£ Áß ¼­ºñ½º ¼ö¿ä¸¦ ÃËÁøÇÏ´Â µ¥ Å« ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀåÀº °Ô³ð ¿¬±¸¿¡ ´ëÇÑ ÅõÀÚ¿Í ¹ßÀüÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Ȱ¼ºÈ­µÇ°í ÀÖ½À´Ï´Ù. ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ±â¼ú¿¡ ÅõÀÚÇÏ´Â ±â¾÷°ú ¿¬±¸±â°üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ½ÃÀåÀº ÇâÈÄ ¼ö³â°£ Å« ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ ÀÌ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷°£ÀÇ Á¦ÈÞ ¹× ÆÄÆ®³Ê½Ê Áõ°¡µµ ½ÃÀå ¼ºÀå¿¡ ±â¿©ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

ÇÕ¼ºÀ» ÅëÇÑ ½ÃÄö½º ºÎ¹®ÀÌ °¡Àå Å« ºñÁßÀ» Â÷ÁöÇߴµ¥, ÀÌ´Â Á¤ÇØÁø ½Ã°£ ¹× ºñ¿ë ³»¿¡¼­ º´·Ä ½ÖÀÇ ½ÃÄö½º¸¦ ½ÇÇàÇÒ ¼ö Àֱ⠶§¹®ÀÎ °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù.

ÁÖ·Î Àå Áúȯ ȯÀÚ ¼ö Áõ°¡¿Í »ýȰ½À°ü º¯È­·Î ÀÎÇÑ Àå³» ¼¼±ÕÃÑ ¼Õ»óÀ¸·Î ÀÎÇØ ¼ÒÈ­±â ºÎ¹®ÀÌ °¡Àå Å« ¸ÅÃâÀ» Â÷ÁöÇß½À´Ï´Ù.

¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ¿¬±¸¿¡ ´ëÇÑ ÀÚ±Ý Áö¿ø Áõ°¡¿Í ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ºÐ¼®¿¡ ´ëÇÑ Àü±¹ÀûÀÎ ÇÁ·Î±×·¥À¸·Î ÀÎÇØ ¿¬±¸ ±â°üÀÌ Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

ºÏ¹Ì°¡ Çõ½ÅÀûÀÎ ±â¾÷ÀÇ Á¸Àç, ³·Àº ½ÃÄö½Ì ºñ¿ë, ´ë±Ô¸ð ÅõÀÚ·Î ÀÎÇØ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ¼¼°èÀÇ ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå ÀλçÀÌÆ®

  • ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå - ÃÖÁ¾ ¿ëµµ ½º³À¼ô
  • ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå ¿ªÇÐ
    • ÃËÁø¿äÀΰú ±âȸ
      • Â÷¼¼´ë ½ÃÄö½Ì¿¡¼­ ±â¼úÀÇ Áøº¸
      • ¿¬±¸°³¹ß Ȱµ¿¿¡ ´ëÇÑ ÅõÀÚ¿¡ ÀÇÇÑ ±â¾÷¿¡ ÀÇÇÑ ¾Æ¿ô¼Ò½Ì ¼­ºñ½ºÀÇ Áõ°¡µµ ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÏ´Â Áß¿äÇÑ ¿äÀÎÀÌ´Ù.
    • ¾ïÁ¦¿äÀΰú °úÁ¦
      • ¼÷·Ã ÀÎÀçÀÇ ºÎÁ·
  • PESTEL ºÐ¼®
  • ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå ÃÖÁ¾ »ç¿ë µ¿Çâ
  • ¹ë·ùüÀÎ ºÐ¼®
  • COVID-19 °¨¿°ÁõÀÇ ¿µÇ⠺м®

Á¦5Àå ¼¼°èÀÇ ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå, Å×Å©³î·¯Áöº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­·Ð
  • ÇÕ¼º¿¡ ÀÇÇÑ ¹è¿­ °áÁ¤
  • ¶óÀ̰ÔÀ̼ǿ¡ ÀÇÇÑ ¹è¿­ °áÁ¤
  • »ý¾î ¹è¿­ °áÁ¤
  • ±âŸ

Á¦6Àå ¼¼°èÀÇ ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå, ¾ÖÇø®ÄÉÀ̼Ǻ°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­·Ð
  • ÀÚ°¡¸é¿ªÁúȯ
  • ¾Ï
  • À§Àå Àå¾Ö
  • ±âŸ

Á¦7Àå ¼¼°èÀÇ ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå, ÃÖÁ¾ »ç¿ëº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­·Ð
  • Á¦¾àȸ»ç ¹× ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ȸ»ç
  • Çмú Á¶»ç±â°ü
  • ±âŸ

Á¦8Àå ¼¼°èÀÇ ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå, Áö¿ªº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­·Ð
    • ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå Æò°¡, Áö¿ª,2019-2032³â
  • ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå - ºÏ¹Ì
    • ºÏ¹Ì : ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå, Å×Å©³î·¯Áöº°, 2019-2032³â
    • ºÏ¹Ì : ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå, ÃÖÁ¾ »ç¿ëº°, 2019-2032³â
    • ºÏ¹Ì : ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå, ¾ÖÇø®ÄÉÀ̼Ǻ°, 2019-2032³â
    • ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå - ¹Ì±¹
    • ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå - ij³ª´Ù
  • ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå - À¯·´
    • À¯·´ : ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå, Å×Å©³î·¯Áöº°, 2019-2032³â
    • À¯·´ : ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå, ÃÖÁ¾ »ç¿ëº°, 2019-2032
    • À¯·´ : ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå, ¾ÖÇø®ÄÉÀ̼Ǻ°, 2019-2032³â
    • ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå - ¿µ±¹
    • ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå - ÇÁ¶û½º
    • ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå - µ¶ÀÏ
    • ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå - ÀÌÅ»¸®¾Æ
    • ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå - ½ºÆäÀÎ
    • ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå - ³×´ú¶õµå
    • ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå - ·¯½Ã¾Æ
  • ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå - ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå, Å×Å©³î·¯Áöº°, 2019-2032³â
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå, ÃÖÁ¾ »ç¿ëº°, 2019-2032³â
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå, ¾ÖÇø®ÄÉÀ̼Ǻ°, 2019-2032³â
    • ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå - Áß±¹
    • ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå - Àεµ
    • ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå - ¸»·¹À̽þÆ
    • ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå - ÀϺ»
    • ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå - Àεµ³×½Ã¾Æ
    • ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå - Çѱ¹
  • ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå - Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå, Å×Å©³î·¯Áöº°, 2019-2032³â
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå, ÃÖÁ¾ »ç¿ëº°, 2019-2032³â
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå, ¾ÖÇø®ÄÉÀ̼Ǻ°, 2019-2032³â
    • ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå - »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå - ¾Æ¶ø¿¡¹Ì¸®Æ®
    • ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå - À̽º¶ó¿¤
    • ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå - ³²¾ÆÇÁ¸®Ä«
  • ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå - ¶óƾ¾Æ¸Þ¸®Ä«
    • ¶óƾ¾Æ¸Þ¸®Ä« : ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå, Å×Å©³î·¯Áöº°, 2019-2032³â
    • ¶óƾ¾Æ¸Þ¸®Ä« : ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå, ÃÖÁ¾ »ç¿ëº°, 2019-2032
    • ¶óƾ¾Æ¸Þ¸®Ä« : ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå, ¾ÖÇø®ÄÉÀ̼Ǻ°, 2019-2032³â
    • ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå - ¸ß½ÃÄÚ
    • ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå - ºê¶óÁú
    • ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå - ¾Æ¸£ÇîÆ¼³ª

Á¦9Àå °æÀï ±¸µµ

  • È®Àå°ú Àμö ºÐ¼®
    • È®´ë
    • Àμö
  • Á¦ÈÞ/Çù¾÷/ÇÕÀÇ/°ø°³

Á¦10Àå ±â¾÷ °³¿ä

  • Microbiome Insights
  • .Baseclear
  • Clinical-Microbiomics
  • Merieux NutriSciences Corp
  • MR DNA
  • Metabiomics Corp
  • Rancho BioSciences
  • Second Genome
  • Zymo Research Corporation
  • uBiome.
KSA 23.10.23

The global microbiome sequencing services market size is expected to reach USD 1,032.39 million by 2032, according to a new study by Polaris Market Research. The report "Microbiome Sequencing Services Market Share, Size, Trends, Industry Analysis Report, By Technology (Sequencing By Synthesis, Sequencing By Ligation, Sanger Sequencing), By Application, By End-user, By Region, And Segment Forecasts, 2023 - 2030" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The significant impact of microbiomes on human health has driven substantial progress in microbiome sequencing research over the past few years. With advances in sequencing technologies and substantial reductions in the costs of these services, it has become easier to conduct studies on the diversity of microbes present in and on the human body. The potential for developing novel treatments and preventative measures for various diseases, including cancer, auto-immune conditions, & infectious diseases, has driven research on the human body's microbiome impacts human physiology. The growing research in this field is likely to drive demand for microbiome sequencing services as scientists and researchers continue to explore the relationship between the microbiome and human health.

The COVID-19 pandemic has indeed had a positive impact on the market for microbiome sequencing services. The pandemic led to an increased adoption of microbiome sequencing tools, especially in the fields of infectious diseases and cancer research. RNA sequencing, which is one of the applications of microbiome sequencing, was utilized to determine the presence of the virus and the host's response to COVID-19. This increased demand for microbiome sequencing services and tools during the pandemic is expected to continue to drive market growth in the coming years.

Government funding for research on COVID-19 and partnerships with industry participants have also played a significant role in fueling the demand for the services during the pandemic. The microbiome sequencing services market is also being fueled by rising investment & advancements in the genomic research. As more companies and research institutions invest in microbiome sequencing technologies, the market is expected to see significant growth in the coming years. Additionally, the increasing number of collaborations and partnerships among key players in the market is also expected to contribute to market growth.

Microbiome Sequencing Services Market Report Highlights

Sequence by synthesis segment held the largest share, owing to its ability to run parallel pairs of sequences within stipulated time and cost

Gastro-intestinal segment held largest revenue, primarily due to rise in cases of bowel diseases and damages in the gut micro-biota due to changing life-style

Research institutes garnered substantial share, owing to rise funding for microbiome research and nationwide programs on micro-biome analysis

North America is held the largest share, due presence of innovative companies, decline in sequencing costs, and significant investments

The global players include: Microbiome Insights, Baseclear, Clinical-Microbiomics, Merieux NutriSciences Corp., MR DNA, Metabiomics Corp., Rancho BioSciences, Second Genome, Zymo Research Corporation, and uBiome.

Polaris Market Research has segmented the microbiome sequencing services market report based on technology, application, end use, and region:

Microbiome Sequencing Services, Technology Outlook (Revenue - USD Million, 2019 - 2032)

  • Sequencing by synthesis
  • Sequencing by ligation
  • Sanger sequencing
  • Others

Microbiome Sequencing Services, Application Outlook (Revenue - USD Million, 2019 - 2032)

  • Autoimmune Disorder
  • Cancer
  • Gastrointestinal Disorders
  • Others

Microbiome Sequencing Services, End Use Outlook (Revenue - USD Million, 2019 - 2032)

  • Pharmaceutical & biotechnology companies
  • Academic research institutes
  • Others

Microbiome Sequencing Services, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Microbiome Sequencing Services Market Insights

  • 4.1. Microbiome Sequencing Services Market - End Use Snapshot
  • 4.2. Microbiome Sequencing Services Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1.Technological advancements in next-generation sequencing
      • 4.2.1.2. Increasing outsourcing services by companies due to investments in R&D activities is also a key factor propelling the growth of the market
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Shortage of skilled personnel
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Microbiome Sequencing Services Market End Use Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Microbiome Sequencing Services Market, by Technology

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Microbiome Sequencing Services Market, by Technology, 2019-2032 (USD Million)
  • 5.3.Sequencing by synthesis
    • 5.3.1. Global Microbiome Sequencing Services Market, by Sequencing by synthesis, by Region, 2019-2032 (USD Million)
  • 5.4. Sequencing by ligation
    • 5.4.1. Global Microbiome Sequencing Services Market, by Sequencing by ligation, by Region, 2019-2032 (USD Million)
  • 5.5. Sanger sequencing
    • 5.5.1. Global Microbiome Sequencing Services Market, by Sanger sequencing, by Region, 2019-2032 (USD Million)
  • 5.6. Others
    • 5.6.1. Global Microbiome Sequencing Services Market, by Others, by Region, 2019-2032 (USD Million)

6. Global Microbiome Sequencing Services Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Microbiome Sequencing Services Market, by Application, 2019-2032 (USD Million)
  • 6.3. Autoimmune Disorder
    • 6.3.1. Global Microbiome Sequencing Services Market, by Autoimmune Disorder, by Region, 2019-2032 (USD Million)
  • 6.4. Cancer
    • 6.4.1. Global Microbiome Sequencing Services Market, by Cancer, by Region, 2019-2032 (USD Million)
  • 6.5. Gastrointestinal Disorders
    • 6.5.1. Global Microbiome Sequencing Services Market, by Gastrointestinal Disorders, by Region, 2019-2032 (USD Million)
  • 6.6. Others
    • 6.6.1. Global Microbiome Sequencing Services Market, by Others, by Region, 2019-2032 (USD Million)

7. Global Microbiome Sequencing Services Market, by End Use

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Microbiome Sequencing Services Market, by End Use, 2019-2032 (USD Million)
  • 7.3. Pharmaceutical & biotechnology companies
    • 7.3.1. Global Microbiome Sequencing Services Market, by Pharmaceutical & biotechnology companies, By Region, 2019-2032 (USD Million)
  • 7.4. Academic research institutes
    • 7.4.1. Global Microbiome Sequencing Services Market, by Academic research institutes, By Region, 2019-2032 (USD Million)
  • 7.7. Others
    • 7.7.1. Global Microbiome Sequencing Services Market, by Others, By Region, 2019-2032 (USD Million)

8. Global Microbiome Sequencing Services Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Microbiome Sequencing Services Market Assessment, By Geography, 2019-2032 (USD Million)
  • 8.3. Microbiome Sequencing Services Market - North America
    • 8.3.1. North America: Microbiome Sequencing Services Market, by Technology, 2019-2032 (USD Million)
    • 8.3.2. North America: Microbiome Sequencing Services Market, by End Use, 2019-2032 (USD Million)
    • 8.3.3. North America: Microbiome Sequencing Services Market, by Application, 2019-2032 (USD Million)
    • 8.3.4. Microbiome Sequencing Services Market - U.S.
      • 8.3.4.1. U.S.: Microbiome Sequencing Services Market, by Technology, 2019-2032 (USD Million)
      • 8.3.4.2. U.S.: Microbiome Sequencing Services Market, by End Use, 2019-2032 (USD Million)
      • 8.3.4.3. U.S.: Microbiome Sequencing Services Market, by Application, 2019-2032 (USD Million)
    • 8.3.5. Microbiome Sequencing Services Market - Canada
      • 8.3.5.1. Canada: Microbiome Sequencing Services Market, by Technology, 2019-2032 (USD Million)
      • 8.3.5.2. Canada.: Microbiome Sequencing Services Market, by End Use, 2019-2032 (USD Million)
      • 8.3.5.3. Canada: Microbiome Sequencing Services Market, by Application, 2019-2032 (USD Million)
  • 8.4. Microbiome Sequencing Services Market - Europe
    • 8.4.1. Europe: Microbiome Sequencing Services Market, by Technology, 2019-2032 (USD Million)
    • 8.4.2. Europe.: Microbiome Sequencing Services Market, by End Use, 2019-2032 (USD Million)
    • 8.4.3. Europe: Microbiome Sequencing Services Market, by Application, 2019-2032 (USD Million)
    • 8.4.4. Microbiome Sequencing Services Market - UK
      • 8.4.4.1. UK: Microbiome Sequencing Services Market, by Technology, 2019-2032 (USD Million)
      • 8.4.4.2. UK.: Microbiome Sequencing Services Market, by End Use, 2019-2032 (USD Million)
      • 8.4.4.3. UK: Microbiome Sequencing Services Market, by Application, 2019-2032 (USD Million)
    • 8.4.5. Microbiome Sequencing Services Market - France
      • 8.4.5.1. France: Microbiome Sequencing Services Market, by Technology, 2019-2032 (USD Million)
      • 8.4.5.2. France.: Microbiome Sequencing Services Market, by End Use, 2019-2032 (USD Million)
      • 8.4.5.3. France: Microbiome Sequencing Services Market, by Application, 2019-2032 (USD Million)
    • 8.4.6. Microbiome Sequencing Services Market - Germany
      • 8.4.6.1. Germany: Microbiome Sequencing Services Market, by Technology, 2019-2032 (USD Million)
      • 8.4.6.2. Germany.: Microbiome Sequencing Services Market, by End Use, 2019-2032 (USD Million)
      • 8.4.6.3. Germany: Microbiome Sequencing Services Market, by Application, 2019-2032 (USD Million)
    • 8.4.7. Microbiome Sequencing Services Market - Italy
      • 8.4.7.1. Italy: Microbiome Sequencing Services Market, by Technology, 2019-2032 (USD Million)
      • 8.4.7.2. Italy.: Microbiome Sequencing Services Market, by End Use, 2019-2032 (USD Million)
      • 8.4.7.3. Italy: Microbiome Sequencing Services Market, by Application, 2019-2032 (USD Million)
    • 8.4.8. Microbiome Sequencing Services Market - Spain
      • 8.4.8.1. Spain: Microbiome Sequencing Services Market, by Technology, 2019-2032 (USD Million)
      • 8.4.8.2. Spain.: Microbiome Sequencing Services Market, by End Use, 2019-2032 (USD Million)
      • 8.4.8.3. Spain: Microbiome Sequencing Services Market, by Application, 2019-2032 (USD Million)
    • 8.4.9. Microbiome Sequencing Services Market - Netherlands
      • 8.4.9.1. Netherlands: Microbiome Sequencing Services Market, by Technology, 2019-2032 (USD Million)
      • 8.4.9.2. Netherlands.: Microbiome Sequencing Services Market, by End Use, 2019-2032 (USD Million)
      • 8.4.9.3. Netherlands: Microbiome Sequencing Services Market, by Application, 2019-2032 (USD Million)
    • 8.4.10. Microbiome Sequencing Services Market - Russia
      • 8.4.10.1. Russia: Microbiome Sequencing Services Market, by Technology, 2019-2032 (USD Million)
      • 8.4.10.2. Russia.: Microbiome Sequencing Services Market, by End Use, 2019-2032 (USD Million)
      • 8.4.10.3. Russia: Microbiome Sequencing Services Market, by Application, 2019-2032 (USD Million)
  • 8.5. Microbiome Sequencing Services Market - Asia Pacific
    • 8.5.1. Asia Pacific: Microbiome Sequencing Services Market, by Technology, 2019-2032 (USD Million)
    • 8.5.2. Asia Pacific.: Microbiome Sequencing Services Market, by End Use, 2019-2032 (USD Million)
    • 8.5.3. Asia Pacific: Microbiome Sequencing Services Market, by Application, 2019-2032 (USD Million)
    • 8.5.4. Microbiome Sequencing Services Market - China
      • 8.5.4.1. China: Microbiome Sequencing Services Market, by Technology, 2019-2032 (USD Million)
      • 8.5.4.2. China.: Microbiome Sequencing Services Market, by End Use, 2019-2032 (USD Million)
      • 8.5.4.3. China: Microbiome Sequencing Services Market, by Application, 2019-2032 (USD Million)
    • 8.5.5. Microbiome Sequencing Services Market - India
      • 8.5.5.1. India: Microbiome Sequencing Services Market, by Technology, 2019-2032 (USD Million)
      • 8.5.5.2. India.: Microbiome Sequencing Services Market, by End Use, 2019-2032 (USD Million)
      • 8.5.5.3. India: Microbiome Sequencing Services Market, by Application, 2019-2032 (USD Million)
    • 8.5.6. Microbiome Sequencing Services Market - Malaysia
      • 8.5.6.1. Malaysia: Microbiome Sequencing Services Market, by Technology, 2019-2032 (USD Million)
      • 8.5.6.2. Malaysia.: Microbiome Sequencing Services Market, by End Use, 2019-2032 (USD Million)
      • 8.5.6.3. Malaysia: Microbiome Sequencing Services Market, by Application, 2019-2032 (USD Million)
    • 8.5.7. Microbiome Sequencing Services Market - Japan
      • 8.5.7.1. Japan: Microbiome Sequencing Services Market, by Technology, 2019-2032 (USD Million)
      • 8.5.7.2. Japan.: Microbiome Sequencing Services Market, by End Use, 2019-2032 (USD Million)
      • 8.5.7.3. Japan: Microbiome Sequencing Services Market, by Application, 2019-2032 (USD Million)
    • 8.5.8. Microbiome Sequencing Services Market - Indonesia
      • 8.5.8.1. Indonesia: Microbiome Sequencing Services Market, by Technology, 2019-2032 (USD Million)
      • 8.5.8.2. Indonesia.: Microbiome Sequencing Services Market, by End Use, 2019-2032 (USD Million)
      • 8.5.8.3. Indonesia: Microbiome Sequencing Services Market, by Application, 2019-2032 (USD Million)
    • 8.5.9. Microbiome Sequencing Services Market - South Korea
      • 8.5.9.1. South Korea: Microbiome Sequencing Services Market, by Technology, 2019-2032 (USD Million)
      • 8.5.9.2. South Korea.: Microbiome Sequencing Services Market, by End Use, 2019-2032 (USD Million)
      • 8.5.9.3. South Korea: Microbiome Sequencing Services Market, by Application, 2019-2032 (USD Million)
  • 8.6. Microbiome Sequencing Services Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Microbiome Sequencing Services Market, by Technology, 2019-2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Microbiome Sequencing Services Market, by End Use, 2019-2032 (USD Million)
    • 8.6.3. Middle East & Africa: Microbiome Sequencing Services Market, by Application, 2019-2032 (USD Million)
    • 8.6.4. Microbiome Sequencing Services Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Microbiome Sequencing Services Market, by Technology, 2019-2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Microbiome Sequencing Services Market, by End Use, 2019-2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Microbiome Sequencing Services Market, by Application, 2019-2032 (USD Million)
    • 8.6.5. Microbiome Sequencing Services Market - UAE
      • 8.6.5.1. UAE: Microbiome Sequencing Services Market, by Technology, 2019-2032 (USD Million)
      • 8.6.5.2. UAE.: Microbiome Sequencing Services Market, by End Use, 2019-2032 (USD Million)
      • 8.6.5.3. UAE: Microbiome Sequencing Services Market, by Application, 2019-2032 (USD Million)
    • 8.6.6. Microbiome Sequencing Services Market - Israel
      • 8.6.6.1. Israel: Microbiome Sequencing Services Market, by Technology, 2019-2032 (USD Million)
      • 8.6.6.2. Israel.: Microbiome Sequencing Services Market, by End Use, 2019-2032 (USD Million)
      • 8.6.6.3. Israel: Microbiome Sequencing Services Market, by Application, 2019-2032 (USD Million)
    • 8.6.7. Microbiome Sequencing Services Market - South Africa
      • 8.6.7.1. South Africa: Microbiome Sequencing Services Market, by Technology, 2019-2032 (USD Million)
      • 8.6.7.2. South Africa.: Microbiome Sequencing Services Market, by End Use, 2019-2032 (USD Million)
      • 8.6.7.3. South Africa: Microbiome Sequencing Services Market, by Application, 2019-2032 (USD Million)
  • 8.7. Microbiome Sequencing Services Market - Latin America
    • 8.7.1. Latin America: Microbiome Sequencing Services Market, by Technology, 2019-2032 (USD Million)
    • 8.7.2. Latin America.: Microbiome Sequencing Services Market, by End Use, 2019-2032 (USD Million)
    • 8.7.3. Latin America: Microbiome Sequencing Services Market, by Application, 2019-2032 (USD Million)
    • 8.7.4. Microbiome Sequencing Services Market - Mexico
      • 8.7.4.1. Mexico: Microbiome Sequencing Services Market, by Technology, 2019-2032 (USD Million)
      • 8.7.4.2. Mexico.: Microbiome Sequencing Services Market, by End Use, 2019-2032 (USD Million)
      • 8.7.4.3. Mexico: Microbiome Sequencing Services Market, by Application, 2019-2032 (USD Million)
    • 8.7.5. Microbiome Sequencing Services Market - Brazil
      • 8.7.5.1. Brazil: Microbiome Sequencing Services Market, by Technology, 2019-2032 (USD Million)
      • 8.7.5.2. Brazil.: Microbiome Sequencing Services Market, by End Use, 2019-2032 (USD Million)
      • 8.7.5.3. Brazil: Microbiome Sequencing Services Market, by Application, 2019-2032 (USD Million)
    • 8.7.6. Microbiome Sequencing Services Market - Argentina
      • 8.7.6.1. Argentina: Microbiome Sequencing Services Market, by Technology, 2019-2032 (USD Million)
      • 8.7.6.2. Argentina.: Microbiome Sequencing Services Market, by End Use, 2019-2032 (USD Million)
      • 8.7.6.3. Argentina: Microbiome Sequencing Services Market, by Application, 2019-2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Microbiome Insights
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. .Baseclear
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Clinical-Microbiomics
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Merieux NutriSciences Corp
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. MR DNA
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6.Metabiomics Corp
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Rancho BioSciences
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Second Genome
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Zymo Research Corporation
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. uBiome.
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦